Click to join an upcoming live event

Turn off Ads (click)

Click on your language to translate this article:

Afrikaans Afrikaans Albanian Albanian Amharic Amharic Arabic Arabic Armenian Armenian Azerbaijani Azerbaijani Basque Basque Belarusian Belarusian Bengali Bengali Bosnian Bosnian Bulgarian Bulgarian Catalan Catalan Cebuano Cebuano Chichewa Chichewa Chinese (Simplified) Chinese (Simplified) Chinese (Traditional) Chinese (Traditional) Corsican Corsican Croatian Croatian Czech Czech Danish Danish Dutch Dutch English English Esperanto Esperanto Estonian Estonian Filipino Filipino Finnish Finnish French French Frisian Frisian Galician Galician Georgian Georgian German German Greek Greek Gujarati Gujarati Haitian Creole Haitian Creole Hausa Hausa Hawaiian Hawaiian Hebrew Hebrew Hindi Hindi Hmong Hmong Hungarian Hungarian Icelandic Icelandic Igbo Igbo Indonesian Indonesian Irish Irish Italian Italian Japanese Japanese Javanese Javanese Kannada Kannada Kazakh Kazakh Khmer Khmer Korean Korean Kurdish (Kurmanji) Kurdish (Kurmanji) Kyrgyz Kyrgyz Lao Lao Latin Latin Latvian Latvian Lithuanian Lithuanian Luxembourgish Luxembourgish Macedonian Macedonian Malagasy Malagasy Malay Malay Malayalam Malayalam Maltese Maltese Maori Maori Marathi Marathi Mongolian Mongolian Myanmar (Burmese) Myanmar (Burmese) Nepali Nepali Norwegian Norwegian Pashto Pashto Persian Persian Polish Polish Portuguese Portuguese Punjabi Punjabi Romanian Romanian Russian Russian Samoan Samoan Scottish Gaelic Scottish Gaelic Serbian Serbian Sesotho Sesotho Shona Shona Sindhi Sindhi Sinhala Sinhala Slovak Slovak Slovenian Slovenian Somali Somali Spanish Spanish Sudanese Sudanese Swahili Swahili Swedish Swedish Tajik Tajik Tamil Tamil Telugu Telugu Thai Thai Turkish Turkish Ukrainian Ukrainian Urdu Urdu Uzbek Uzbek Vietnamese Vietnamese Welsh Welsh Xhosa Xhosa Yiddish Yiddish Yoruba Yoruba Zulu Zulu
Germany Travel News Government and Public Sector Tourism News Health News International Visitor News People in Travel & Tourism Tourism News Travel News Travel Wire News

Astra Zeneca back on track as a COVID-19 vaccine

Astra Zeneca back on track as a COVID-19 vaccine
Avatar

Astra Zeneca is a very important vaccine in Germany to respond to the growing COVID-19 pandemic. German authorities put this vaccine on hold after blood clots in the brain were developed as a possible side effect. The hold was lifted.

  1. 2 deaths, 13 cases of blood clots in 1.6 million doses of Astra Zeneca is considered a calculated risk in Germany.
  2. No direct connection between the blood clots and Astra Zeneca was established.
  3. Germany is authorizing to administer Astra Zeneca again as of Friday

It would have been a health disaster, a pharmacist from Cologne told eTurboNews.
today.

After a new recommendation by the EU Medical agency, Astra Zeneca will be given to Germans and other Europeans again as of Friday.

Federal and State authorities in Germany together with the “Paul Ehrlich Institute (PEI) , agreed with the recommendation minimizing the risk of blood clods in the brain after taking the vaccine.

The advantages for the vaccine are more than this small risk. The vaccine is safe and effective, according to a health department spokesperson.

German Health Minister Jens Spahn said this was good news.

After 1.6 million doses of Astra Zeneca administered in Germany, only 13 cases of blood clots in the brain were detected with 3 people dying. Twelve women and one man between 20 and 63 years of age were among the 13 cases.

The German institute is not seeing a direct connection between the development of a blood clot and the vaccine.

Out of 60 million doses of vaccine, and people waiting to be vaccinated in Germany, 17 million have been assigned to receive Astra Zeneca. German authorities promised to catch up on the backlog and added that pharmacies and doctors’ offices will be provided with the vaccine soon.